Q Zhan, J Zhang, Y Lin, W Chen, X Fan… - Frontiers in …, 2023 - frontiersin.org
Sjogren's syndrome (SS) is a chronic autoimmune disease accompanied by multiple lesions. The main manifestations include dryness of the mouth and eyes, along with …
X Chen, H Wu, W Wei - Clinical rheumatology, 2018 - Springer
Sjogren's syndrome (SS) is a systemic autoimmune disease that primarily affects the exocrine glands, resulting in dryness of the eyes and mouth due to lymphocytic infiltration of …
N Holdgate, EW StClair - F1000Research, 2016 - pmc.ncbi.nlm.nih.gov
Primary Sjögren's syndrome, a chronic inflammatory process, is among the most commonly occurring rheumatologic diseases. The clinical hallmark of this disease is exocrine gland …
P Brito-Zerón, S Retamozo, H Gheitasi… - Drugs, 2016 - Springer
Sjögren Syndrome (SS) is a systemic autoimmune disease with a wide clinical spectrum that extends from sicca symptoms of the mucosal surfaces to extra-glandular systemic …
C Delporte, J Perret, MS Soyfoo - Autoimmune Disorders; Huang …, 2011 - books.google.com
Sjogren's syndrome (SS) is a chronic autoimmune disease characterized by the lymphocytic infiltration of exocrine glands, mainly the salivary and lachrymal glands entailing the …
CC Mok - Hong Kong Bulletin on Rheumatic Diseases, 2017 - sciendo.com
Primary Sjogren's syndrome (SS) is a systemic autoimmune disease that primarily affects the exocrine glands, resulting in dryness of the mucosal membranes, particularly of the eyes …
B Wang, S Chen, Y Li, J Xuan, Y Liu, G Shi - BioDrugs, 2021 - Springer
Primary Sjögren's syndrome (pSS) is an autoimmune exocrinopathy characterized by dryness symptoms. This review briefly describes recent advances in the targeted therapies …
S Retamozo, A Sisó-Almirall… - Expert Opinion on …, 2021 - Taylor & Francis
ABSTRACT Introduction: Primary Sjögren syndrome (pSS) is a systemic autoimmune disease that may affect 3 in 1,000 people within the general population. The therapeutic …
Primary Sjögren's syndrome (pSS) is a systemic multiorgan autoimmune disease that runs a chronic progressive course. The recently developed treat-to-target paradigm involves …